MedReleaf Brand Profile
MedReleaf Australia is licensed to cultivate and manufacture medical cannabis by the Federal Government’s Office of Drug Control (ODC). We’re striving to improve the lives of Australians with chronic health conditions through the development and innovation of this natural therapy.
There is a way to go in the medical cannabis industry, with plenty of research still to be completed across a range of health conditions. We are driven to continue this Research and Development to further improve the lives of our patients.
MedReleaf Product List
Validation required for access - please validate your medAuth account. If already validated, please sign out of Canna Reviews, and sign back in again.
Swipe left on table to view more detail.
| Form | Product Name | Size | THC | CBD | Feedback | Response | Price |
|---|---|---|---|---|---|---|---|
| Luminarium (Sativa) | 15g | 22.1% | <1% | 16 | 4.2 | $179 | |
| Stellio (Indica) | 15g | 21.5% | <1% | 16 | 3.9 | $179 |
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. CANNABIS IS A SCHEDULED AND REGULATED DRUG.
The information above is not to be taken as medical advice. Cannabis may have negative side effects or interactions with other medications. Medical Cannabis is not effective for everyone and more research needs to be done. Please consult a health professional for advice. Canna Reviews does not receive financial incentives or compensation for displaying product information.